BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3003760)

  • 1. Platelets from aged rats aggregate more, but are more sensitive to prostacyclin.
    Giani E; Masi I; Galli C
    Prostaglandins Leukot Med; 1985 Dec; 20(3):237-46. PubMed ID: 3003760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in platelet thromboxane and arterial prostacyclin production in control and n-6 fatty acid supplemented rats.
    Giani E; Masi I; Colombo C; Galli C
    Prostaglandins; 1984 Oct; 28(4):573-86. PubMed ID: 6441187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular eicosanoids and platelet-aortic wall interactions in spontaneously hypertensive rats.
    Lograno MD; Mosconi C; Marangoni F; Medini L; Grassi G; Galli C
    Eur J Pharmacol; 1991 Sep; 202(3):311-6. PubMed ID: 1721028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased platelet aggregability is associated with increased prostacyclin production by vessel walls in hypercholesterolemic rabbits.
    Tremoli E; Socini A; Petroni A; Galli C
    Prostaglandins; 1982 Sep; 24(3):397-404. PubMed ID: 6818616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fish oil administration as a supplement to a corn oil containing diet affects arterial prostacyclin production more than platelet thromboxane formation in the rat.
    Socini A; Galli C; Colombo C; Tremoli E
    Prostaglandins; 1983 May; 25(5):693-710. PubMed ID: 6310702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced platelet aggregability and increased vascular prostacyclin formation in a variant rat strain (IVA-SIV) with endogenous hypertriglyceridemia.
    Lovati MR; Manzoni C; Mosconi C; Colli S; Sirtori CR; Fumagalli G; Clementi F
    Atherosclerosis; 1988 Nov; 74(1-2):169-77. PubMed ID: 3214476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-vessel wall interactions: effects of platelets and plasma on the antiaggregatory activity and 6 keto-PGF1 alpha production in isolated perfused aortas.
    Galli C; Petroni A; Socini A; Agradi E; Colombo C; Folco GC; Tremoli E
    Prostaglandins; 1981 Nov; 22(5):703-13. PubMed ID: 6276925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in arachidonate metabolism in aortas and platelets in aging rats.
    Chang WC; Tai HH
    Prostaglandins Leukot Med; 1983 Oct; 12(2):149-57. PubMed ID: 6417674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of neferine on platelet aggregation in rabbits].
    Yu J; Hu WS
    Yao Xue Xue Bao; 1997; 32(1):1-4. PubMed ID: 11243209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced platelet sensitivity to prostacyclin in patients in an active stage of Takayasu arteritis.
    Watanabe T; Kishi Y; Numano F; Isobe M
    Thromb Res; 2001 Oct; 104(2):77-83. PubMed ID: 11672751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation and evaluation of the ratio thromboxane B2/6-keto-prostaglandin F1 alpha in the plasma of patients on long term cimetidine treatment.
    Zavagli G; Taddeo U; Bolelli G; Orlandi M; Bartolini G; Tomasi V
    Prostaglandins Leukot Med; 1985 Sep; 19(3):241-50. PubMed ID: 2997804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status.
    Vericel E; Croset M; Sedivy P; Courpron P; Dechavanne M; Lagarde M
    Thromb Res; 1988 Feb; 49(3):331-42. PubMed ID: 3129819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thromboxane-prostacyclin balance and platelet aggregability in patients with minor cardiac abnormalities].
    Iagoda AV; Gladkikh NN
    Ter Arkh; 2010; 82(9):49-53. PubMed ID: 21086621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of vacuum curettage on the concentrations of plasma 6-keto-prostaglandin F1 alpha and serum thromboxane B2.
    Ylikorkala O; Mäkilä UM; Viinikka L
    Br J Obstet Gynaecol; 1983 Mar; 90(3):251-4. PubMed ID: 6338904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation and thromboxane formation by platelets and vascular prostacyclin production from BB rats. An animal model for type I diabetes.
    Landgraf-Leurs MM; Landgraf R; Loy A; Weber PC; Herberg LL
    Prostaglandins; 1982 Jul; 24(1):35-46. PubMed ID: 6812171
    [No Abstract]   [Full Text] [Related]  

  • 17. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose responses in platelet fatty acid composition, aggregation and prostanoid metabolism during moderate freshwater fish diet.
    Agren JJ; Hänninen O; Hänninen A; Seppänen K
    Thromb Res; 1990 Feb; 57(4):565-75. PubMed ID: 2326774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet function in classic migraine during attack-free periods.
    Hedman C; Winther K; Knudsen JB
    Acta Neurol Scand; 1988 Oct; 78(4):271-7. PubMed ID: 2851913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin reduces platelet thromboxane formation and restores normal platelet sensitivity against prostacyclin in type IIa hypercholesterolemia.
    Schrör K; Löbel P; Steinhagen-Thiessen E
    Eicosanoids; 1989; 2(1):39-45. PubMed ID: 2483819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.